Philip Boukas serves as a Valuations Associate at RTW Investments, LP, where he plays a pivotal role in the assessment and valuation of private biotech investments. With his recent accreditation in Business Valuation (ABV) from the American Institute of Certified Public Accountants (AICPA), Philip brings...
Philip Boukas serves as a Valuations Associate at RTW Investments, LP, where he plays a pivotal role in the assessment and valuation of private biotech investments. With his recent accreditation in Business Valuation (ABV) from the American Institute of Certified Public Accountants (AICPA), Philip brings a robust analytical framework to the firm, enhancing its investment strategies and decision-making processes. His expertise lies in constructing detailed valuation and allocation models that are essential for evaluating both existing and prospective investments in the rapidly evolving biotech sector.
Philip's academic background, including an MBA with a concentration in Finance from Fairfield University’s Dolan School of Business, equips him with a solid foundation in financial principles and investment strategies. His proficiency in venture capital, portfolio management, and business valuation allows him to navigate complex financial landscapes effectively. At RTW, he leverages advanced tools such as Microsoft Excel to perform in-depth financial analyses, ensuring that investment decisions are data-driven and aligned with the firm’s strategic objectives.
Key projects that Philip has led include the development of comprehensive valuation models that assess the potential of innovative biotech companies, identifying growth opportunities while mitigating risks. His commitment to excellence in customer service and leadership further enhances his contributions to the team, fostering collaboration and driving successful outcomes. As the biotech industry continues to expand, Philip’s insights and analytical skills position him as a valuable asset to RTW Investments, LP, ensuring that the firm remains at the forefront of investment excellence.
